2015
DOI: 10.12688/f1000research.6075.2
|View full text |Cite
|
Sign up to set email alerts
|

The endothelial deprotection hypothesis for lupus pathogenesis: the dual role of C1q as a mediator of clearance and regulator of endothelial permeability

Abstract: Systemic lupus erythematosus (SLE) is a heterogeneous multifactorial systemic autoimmune disease affecting several organs. SLE can start relatively early in life and results in impaired quality of life and shortened life expectancy because of a gradual disease progression leading to cardiovascular, renal and neoplastic disease. The basic mechanisms of the pathogenesis of the disease still remain to be clarified. It is clear that complement proteins play a key and complex role in the development of SLE. Complem… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
6
0

Year Published

2016
2016
2025
2025

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(7 citation statements)
references
References 117 publications
1
6
0
Order By: Relevance
“…Furthermore, in the last years, C1q has been demonstrated to be of importance in vascular endothelial permeability and integrity. C1q and mannose-binding lectin have been reported in in vitro studies to help in the removal of atherogenic lipoproteins, which has been proposed as a link between C1q deficiency and cardiovascular disease in SLE, as seen in our patient (36, 37). …”
Section: Discussionsupporting
confidence: 57%
“…Furthermore, in the last years, C1q has been demonstrated to be of importance in vascular endothelial permeability and integrity. C1q and mannose-binding lectin have been reported in in vitro studies to help in the removal of atherogenic lipoproteins, which has been proposed as a link between C1q deficiency and cardiovascular disease in SLE, as seen in our patient (36, 37). …”
Section: Discussionsupporting
confidence: 57%
“…SLE is a chronic systemic autoimmune disease, characterized by loss of immunological tolerance of B cells, with the subsequent autoantibody production against double-stranded DNA, nuclear proteins such as Smith (Sm) and phospholipids, among others [ 8 , 9 ]. These antibodies may directly bind to endothelial cells or are part of the circulating IC that can be deposited in the vessels, promoting inflammatory responses of innate immune cells and increasing endothelial permeability and leukocyte infiltration to the affected tissues [ 9 ].…”
Section: Endothelial Alterations In Sle and Ra: Potential Contribumentioning
confidence: 99%
“…SLE is a chronic systemic autoimmune disease, characterized by loss of immunological tolerance of B cells, with the subsequent autoantibody production against double-stranded DNA, nuclear proteins such as Smith (Sm) and phospholipids, among others [ 8 , 9 ]. These antibodies may directly bind to endothelial cells or are part of the circulating IC that can be deposited in the vessels, promoting inflammatory responses of innate immune cells and increasing endothelial permeability and leukocyte infiltration to the affected tissues [ 9 ]. In addition, the continuous exposure of patrolling monocytes of these patients to circulating autoantibodies and IC may also lead to chronic endothelial cell activation mediated by the interaction with monocytes, causing injuries of blood vessels and vasculitis [ 43 ].…”
Section: Endothelial Alterations In Sle and Ra: Potential Contribumentioning
confidence: 99%
“…SLE may affect the integrity and repair mechanisms of endothelial cells through direct binding of antibodies to endothelial cells or deposition of circulating immune complexes. This then results in endothelial damage that promotes atherogenesis 6. Accelerated atherosclerosis in SLE may also be related to the presence of antiphospholipid antibodies, which increase the risk of thrombosis in SLE 7–9…”
Section: Introductionmentioning
confidence: 99%